CD33 and myeloid sarcoma: As a result, the calculated SF value of 0.62 significantly deviated from 1 (p = 0.032), suggesting that CD33 rs3865444 A and HLA-DRB1*15:01 alleles displayed an antagonistic statistical interaction in the context of MS risk.